Piper Sandler on Guardant Health (GH): 'Investors can take this opportunity to add to their position'
September 15, 2026 11:02 AM
Piper Sandler analyst David Westenberg reiterated an Overweight rating and $193.00 price target on Guardant Health (NASDAQ: GH).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
